Lineage Cell Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LCTX and other ETFs, options, and stocks.

About LCTX

Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery. 

CEO
Brian M. Culley
CEOBrian M. Culley
Employees
61
Employees61
Headquarters
Carlsbad, California
HeadquartersCarlsbad, California
Founded
1990
Founded1990
Employees
61
Employees61

LCTX Key Statistics

Market cap
195.22M
Market cap195.22M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
325.14K
Average volume325.14K
High today
$1.17
High today$1.17
Low today
$1.12
Low today$1.12
Open price
$1.14
Open price$1.14
Volume
118.09K
Volume118.09K
52 Week high
$2.71
52 Week high$2.71
52 Week low
$1.10
52 Week low$1.10

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

LCTX Earnings

-$0.17
-$0.11
-$0.05
$0.01
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 10, After Hours
ActualExpected Nov 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.